These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8056700)

  • 1. A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient.
    Vance-Bryan K; Rotschafer JC; Gilliland SS; Rodvold KA; Fitzgerald CM; Guay DR
    J Antimicrob Chemother; 1994 Apr; 33(4):811-21. PubMed ID: 8056700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster.
    Guay DR; Vance-Bryan K; Gilliland S; Rodvold K; Rotschafer J
    J Clin Pharmacol; 1993 Oct; 33(10):918-22. PubMed ID: 8227461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of vancomycin-associated nephrotoxicity.
    Moh'd H; Kheir F; Kong L; Du P; Farag H; Mohamad A; Zurlo JJ
    South Med J; 2014 Jun; 107(6):383-8. PubMed ID: 24945176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors.
    Meaney CJ; Hynicka LM; Tsoukleris MG
    Pharmacotherapy; 2014 Jul; 34(7):653-61. PubMed ID: 24700598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
    Dong MH; Wang JW; Wu Y; Chen BY; Yu M; Wen AD
    Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin.
    Zasowski EJ; Murray KP; Trinh TD; Finch NA; Pogue JM; Mynatt RP; Rybak MJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A; Mergenhagen KA; Mattappallil A
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination.
    Goetz MB; Sayers J
    J Antimicrob Chemother; 1993 Aug; 32(2):325-34. PubMed ID: 8226435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
    Masuda N; Maiguma T; Komoto A; Haruki Y; Sugiyama T; Kondo S; Teshima D
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.
    Huang M; Wu H; Zhou J; Xu M; Zhou S
    Arch Iran Med; 2018 Aug; 21(8):349-355. PubMed ID: 30113856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk factors for vancomycin-induced nephrotoxicity.
    Park SJ; Lim NR; Park HJ; Yang JW; Kim MJ; Kim K; In YW; Lee YM
    Int J Clin Pharm; 2018 Oct; 40(5):1328-1334. PubMed ID: 29744794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of a decision tree model for the analysis of adverse drug reactions: Evaluation of a risk prediction model of vancomycin-associated nephrotoxicity constructed using a data mining procedure.
    Imai S; Yamada T; Kasashi K; Kobayashi M; Iseki K
    J Eval Clin Pract; 2017 Dec; 23(6):1240-1246. PubMed ID: 28544476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
    Barberan J; Mensa J; Artero A; Epelde F; Rodriguez JC; Ruiz-Morales J; Calleja JL; Guerra JM; Martínez-Gil I; Giménez MJ; Granizo JJ; Aguilar L
    Rev Esp Quimioter; 2019 Feb; 32(1):22-30. PubMed ID: 30630306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring.
    Han HK; An H; Shin KH; Shin D; Lee SH; Kim JH; Cho SH; Kang HR; Jang IJ; Yu KS; Lim KS
    Ther Drug Monit; 2014 Oct; 36(5):606-11. PubMed ID: 24577126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a vancomycin dosage regimen developed for obese patients.
    Reynolds DC; Waite LH; Alexander DP; DeRyke CA
    Am J Health Syst Pharm; 2012 Jun; 69(11):944-50. PubMed ID: 22610026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.
    Le J; Ny P; Capparelli E; Lane J; Ngu B; Muus R; Romanowski G; Vo T; Bradley J
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e109-16. PubMed ID: 26582878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.